- Home
- PETZ vs CODX Comparison
PETZ vs CODX Comparison
Compare PETZ & CODX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PETZ
- CODX
- Stock Information
- Founded
- PETZ 2002
- CODX 2013
- Country
- PETZ China
- CODX United States
- Employees
- PETZ N/A
- CODX N/A
- Industry
- PETZ Steel/Iron Ore
- CODX Medical/Dental Instruments
- Sector
- PETZ Industrials
- CODX Health Care
- Exchange
- PETZ Nasdaq
- CODX Nasdaq
- Market Cap
- PETZ 9.3M
- CODX 9.8M
- IPO Year
- PETZ 2017
- CODX 2017
- Fundamental
- Price
- PETZ $1.12
- CODX $0.35
- Analyst Decision
- PETZ
- CODX Buy
- Analyst Count
- PETZ 0
- CODX 2
- Target Price
- PETZ N/A
- CODX $5.50
- AVG Volume (30 Days)
- PETZ 101.4K
- CODX 988.1K
- Earning Date
- PETZ 04-28-2025
- CODX 11-06-2025
- Dividend Yield
- PETZ N/A
- CODX N/A
- EPS Growth
- PETZ N/A
- CODX N/A
- EPS
- PETZ 0.26
- CODX N/A
- Revenue
- PETZ $563,726.00
- CODX $1,003,653.00
- Revenue This Year
- PETZ N/A
- CODX N/A
- Revenue Next Year
- PETZ N/A
- CODX $31.58
- P/E Ratio
- PETZ $5.63
- CODX N/A
- Revenue Growth
- PETZ 74664.72
- CODX N/A
- 52 Week Low
- PETZ $0.65
- CODX $0.23
- 52 Week High
- PETZ $1.74
- CODX $1.40
- Technical
- Relative Strength Index (RSI)
- PETZ 58.29
- CODX 65.94
- Support Level
- PETZ $1.02
- CODX $0.30
- Resistance Level
- PETZ $1.20
- CODX $0.37
- Average True Range (ATR)
- PETZ 0.07
- CODX 0.03
- MACD
- PETZ 0.01
- CODX 0.00
- Stochastic Oscillator
- PETZ 53.71
- CODX 77.71
About PETZ TDH Holdings Inc.
TDH Holdings Inc is engaged in the business of manufacturing and selling pet food and restaurant operations. The company has two operating segments, which include Petfood sales and the Restaurant business. It has a focus on the Restaurant business segment and generates the majority of its revenue.
About CODX Co-Diagnostics Inc.
Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV.The Company's technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious diseases.